IDH1 Mutations Disrupt Blood, Brain, and Barriers

Cancer Cell

Volumn 22, Issue 3, 2012, Pages 285-287

  Shih, Alan H ^a   Levine, Ross L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYGLUTARIC ACID; 2 OXOGLUTARIC ACID; 5 HYDROXYMETHYLCYTOSINE; COLLAGEN; HISTONE DEMETHYLASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE 2; MIXED LINEAGE LEUKEMIA PROTEIN; NESTIN; PROCOLLAGEN LYSINE 2 OXOGLUTARATE 5 DIOXYGENASE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ALLELE; ANGIOGENESIS; APOPTOSIS; BILE DUCT CARCINOMA; BLOOD BRAIN BARRIER; BRAIN TUMOR; CANCER GRADING; CANCER INCIDENCE; CHONDROSARCOMA; CITRIC ACID CYCLE; COLORECTAL CANCER; CPG ISLAND; DNA METHYLATION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; ENZYME INHIBITION; EPIGENETICS; GAIN OF FUNCTION MUTATION; GENE EXPRESSION REGULATION; GLIOBLASTOMA; GLIOMA; HEMATOPOIETIC CELL; HISTONE METHYLATION; LEUKEMOGENESIS; MICROENVIRONMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION; THYROID CANCER; TUMOR GROWTH;

MURINAE;

EID: 84866038635     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2012.08.022     Document Type: Short Survey

References (10)

1. Dang L., White D.W., Gross S., Bennett B.D., Bittinger M.A., Driggers E.M., Fantin V.R., Jang H.G., Jin S., Keenan M.C., et al. Nature 2009, 462:739-744.
2. Figueroa M.E., Abdel-Wahab O., Lu C., Ward P.S., Patel J., Shih A., Li Y., Bhagwat N., Vasanthakumar A., Fernandez H.F., et al. Cancer Cell 2010, 18:553-567.
3. Lu C., Ward P.S., Kapoor G.S., Rohle D., Turcan S., Abdel-Wahab O., Edwards C.R., Khanin R., Figueroa M.E., Melnick A., et al. Nature 2012, 483:474-478.
4. Mardis E.R., Ding L., Dooling D.J., Larson D.E., McLellan M.D., Chen K., Koboldt D.C., Fulton R.S., Delehaunty K.D., McGrath S.D., et al. N. Engl. J. Med. 2009, 361:1058-1066.
5. Noushmehr H., Weisenberger D.J., Diefes K., Phillips H.S., Pujara K., Berman B.P., Pan F., Pelloski C.E., Sulman E.P., Bhat K.P., et al. Cancer Cell 2010, 17:510-522. Cancer Genome Atlas Research Network.
6. Sasaki M., Knobbe C.B., Itsumi M., Elia A.J., Harris I.S., Chio I.C., Cairns R.A., McCracken S., Wakeham A., Haight J., et al. Genes Dev. 2012, Published online August 27, 2012. 10.1101/gad.198200.112.
7. Sasaki M., Knobbe C.B., Munger J.C., Lind E.F., Brenner D., Brustle A., Harris I.S., Holmes R., Wakeham A., Haight J., et al. Nature 2012, Published online July 4, 2012. 10.1038/nature11323.
8. Ward P.S., Patel J., Wise D.R., Abdel-Wahab O., Bennett B.D., Coller H.A., Cross J.R., Fantin V.R., Hedvat C.V., Perl A.E., et al. Cancer Cell 2010, 17:225-234.
9. Xu W., Yang H., Liu Y., Yang Y., Wang P., Kim S.H., Ito S., Yang C., Wang P., Xiao M.T., et al. Cancer Cell 2011, 19:17-30.
10. Yan H., Parsons D.W., Jin G., McLendon R., Rasheed B.A., Yuan W., Kos I., Batinic-Haberle I., Jones S., Riggins G.J., et al. N. Engl. J. Med. 2009, 360:765-773.